EGEdward Osei Gyimah

Edward Osei Gyimah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Edward Osei Gyimah has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Selected Immunophenotypic Markers in Childhood Non‐Hodgkin's Lymphomas in Ghana: A Possible Tool for Effective Stratification of Patients and Assessment of Survival Outcomes

    by Samuel Asamoah Sakyi, Bernard Gyan, Ernest Adankwah, Ernest Kwasi Adjei, Vivian Paintsil, David Kwabena Adu, Manu Akwasi Owusu, Clement Binwatin Dagungong, Muniru Mohammed Tanko, Kervin Edinam Zogli, et al.

    Background: Non‐Hodgkin lymphomas (NHL) represent a heterogeneous group of malignancies with varying molecular and immunophenotypic characteristics. In Ghana, NHL is the third most common childhood cancer, highlighting the need for precise diagnostic approaches to improve survival rates. The identification of immunophenotypic biomarkers expressed by both healthy and neoplastic cells of the immune systems has been shown to provide information on the diagnostic and prognostic characterization of tumors leading to personalized treatment of NHL. We evaluated the immunophenotypic profiles of pediatric NHL and their correlation with survival outcomes. Aims: This study aimed to evaluate the immunophenotypic characteristics of three subtypes of non‐Hodgkin lymphoma (NHL) and their associated survival outcomes among children diagnosed at Komfo Anokye Teaching Hospital, Kumasi. Methods: In this retrospective study, 38 NHL patients were recruited from the Komfo Anokye Teaching Hospital from 2018 to 2022. Clinico‐pathological characteristics and treatment outcome were obtained in patients' folders. Formalin fixed paraffin embedded tissues were histologically examined and immunohistochemistry performed using monoclonal antibodies targeting CD3 , CD25 and BCL‐2 . The Kaplan–Meier method was used to obtain survival curves and compared by the log‐rank test. Statistical analysis was performed using SPSS (version 26.0) and XLSTAT. Results: Females accounted for 55.3% of cases, with most patients being under 10 years. Within the first‐year post‐diagnosis, 30.6% of children died, and 27.8% abandoned treatment. BCL‐2 was the most frequently expressed marker (55.3%), with co‐expression observed across all lymphoma types and age groups. Survival analysis was performed on 21/38 participants with complete follow‐up data. The median survival time was 22 months (95% CI: 3.96–40.11), with survival rates declining from 76% at 10 months to 20% at 40 months. Factors significantly associated with poor survival included BCL‐2 expression (poorer survival) and extranodal spread ( p < 0.05). Conclusion: The survival rate for NHL patients in Ghana is very low. BCL‐2 was the most expressed marker, significantly influencing survival outcomes. The extent of tumor spread also influenced survival outcomes. Identifying prognostic factors for early diagnosis and treatment is essential to improving survival outcomes for NHL patients in this setting.

  • Open Access

    Pre‐Eclampsia and Its Associated Factors Among Pregnant Women in Ghana: A Retrospective Study

    by Sabastian Adjei, Wilfred Sam‐Awortwi Jnr, Richmond Adu Boahen Boamah, Edward Osei Gyimah, William Kweku Payne, Harriet Yeboaa Diawuo, Samuel Kwame Sopuruchi Agomuo, Oscar Simon Olympio Mensah, Alfred Effah, Christian Obirikorang

    Background and Aims: Pre‐eclampsia remains a major cause of feto‐maternal death in Ghana, with a rising incidence linked to multiple factors that hinder prevention. Despite it's impact, few studies have explored associated risks. This study assessed the prevalence, risk factors, and maternal–neonatal outcomes associated with pre‐eclampsia among pregnant women at Kumasi South Hospital between January 2020 and May 2025. Methods: A retrospective descriptive study was conducted among 519 pregnant women who delivered at Kumasi South Hospital between January 2020 and May 2025. Data on sociodemographic, obstetric, clinical, and maternal–neonatal outcomes were extracted from medical records. Categorical variables were reported as frequencies and percentages, and binary logistic regression was used to identify independent predictors. p ‐value < 0.05 was considered statistically significant. Results: The prevalence of pre‐eclampsia was 28.1%, with significant associations observed for adverse maternal/neonatal outcomes. After adjusting for multiple confounders, inadequate ANC visits [aOR = 4.79, 95% CI: 1.19–19.23, p = 0.027], headache or visual disturbances [aOR = 8.55, 95% CI: 1.90–38.46, p = 0.005], and low platelet count [aOR = 7.67, 95% CI: 1.96–30.02, p = 0.003] were associated with significantly increased odds of pre‐eclampsia. However, age [aOR= 0.41, 95% CI: 0.21–0.82, p = 0.012], and parity were also associated with reduced risk of pre‐eclampsia. Conclusion: Pre‐eclampsia was common among pregnant women delivering at KSH, negatively impacting maternal and neonatal outcomes. These findings highlight the need for closer antenatal monitoring and early identification of these risk factors to reduce the maternal and neonatal burden of pre‐eclampsia.


  • Open Access

    LDL‐C Estimation in Ghana: A Comparative Study of 13 Calculation Methods

    by Samuel Asamoah Sakyi, Linda Ahenkorah Fondjo, Raphael Osei Mensah-Bonsu, Oscar Simon Olympio Mensah, Samuel Kwarteng, Samuel Kwame Sopuruchi Agomuo, Edward Osei Gyimah, Harriet Yeboaa Diawuo, Godfred Yawson Scott, Richmond Gorman, et al.

    Background: Friedewald′s equation remains the most widely used method for estimating LDL‐C in clinical settings, despite the availability of several homogeneous direct assays. However, its accuracy declines under certain clinical conditions, such as unusually high or low levels of triglycerides and total cholesterol. Recently, several novel population‐specific equations have been reported to outperform the Friedewald equation. This study therefore is aimed at evaluating and comparing the accuracy of 13 LDL‐C estimation equations within the Ghanaian population. Methods: A cross‐sectional study was conducted among 976 individuals at Suntreso Government Hospital, Kumasi, Ghana. Fasting venous blood samples were analyzed for lipid profiles. Direct LDL‐C was enzymatically measured and compared with values calculated using 13 equations. Performance was assessed with Pearson correlations, Bland–Altman plots, and Wilcoxon signed‐rank tests. Results: All 13 equations correlated significantly with direct LDL‐C ( r = 0.563–0.857, p < 0.001), with DeLong, Puavilai, Vujovic, Sampson, Choi, and Martin showing the strongest correlations ( r = 0.857). Ahmadi (71.39 mg/dL), Hattori (44.93 mg/dL), Rao (25.8 mg/dL), and Choi (19.58 mg/dL) were the most overestimated LDL‐C formulas, while de Cordova (−5.59 mg/dL) underestimated the direct LDL‐C measurement. Subgroup analyses by age, triglyceride, and total cholesterol levels revealed that the Friedewald and Chen and Zhang formulas exhibited nonsignificant median differences ( p > 0.05) in individuals aged 18–55 years and those with triglyceride levels ≥ 200 mg/dL. Conclusion: The Sampson, Martin, and Puavilai equations demonstrated the most reliable and consistent performance across age and lipid subgroups and should be considered preferred methods for LDL‐C estimation in clinical and research settings in Ghana. Although Friedewald and Chen and Zhang performed adequately in younger adults and individuals with elevated triglycerides, their overall agreement was weaker, highlighting the broader utility of the Sampson, Martin, and Puavilai equations.